Stay updated with breaking news from Quantoom Biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patrick Thiaville is chief scientific officer of Exothera Nucleic Acids, a viral vector CDMO (contract manufacturing and development organization) using standard and innovative bioproduction platforms to rapidly deliver affordable viral vector-based vaccines and cell and gene therapies.
/PRNewswire/ -- Global Continuous Manufacturing Market Overview The global continuous manufacturing market is growing exponentially; it is estimated to be...
By strengthening the continent's health care infrastructure, promoting local vaccine production, and facilitating global collaborations, the grant represents an important milestone toward better health care for all Africans.
The global rise in tuberculosis cases is showing no signs of slowing down. The need for a new vaccine is as urgent as ever, and now a local pharmaceutical company is joining the race to find one. Find out more about the work it did to propel itself into this position.
The $5bn (about R92bn) needed every year for the next four years for TB vaccine research is the only way to give future generations a shot at ending the disease, experts at the World Conference on Lung Health in Paris said on Thursday.